Other reports in the literature underline the possible role of noncoding RNAs, which are emerging biomarkers in the hypertension field [155], as regulators of endothelial function via the NLRP3 inflammasome signaling pathway [156]. The gene discussed is NLRP3; the disease is hypertensive disorder.